Kevin Joseph Fitzgerald - 17 Nov 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
Issuer symbol
ALNY
Transactions as of
17 Nov 2025
Net transactions value
-$4,511,770
Form type
4
Filing time
19 Nov 2025, 16:05:28 UTC
Previous filing
03 Oct 2025
Next filing
14 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fitzgerald Kevin Joseph CSO & EVP, Head of Research 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald 19 Nov 2025 0001886431

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $972,220 +8,161 +32% $119.13 33,392 17 Nov 2025 Direct F1
transaction ALNY Common Stock Sale $3,667,432 -8,168 -24% $449.00 25,224 17 Nov 2025 Direct F1
transaction ALNY Common Stock Sale $43,209 -96 -0.38% $450.09 25,128 17 Nov 2025 Direct F1
transaction ALNY Common Stock Sale $58,245 -129 -0.51% $451.51 24,999 17 Nov 2025 Direct F1, F2
transaction ALNY Common Stock Sale $167,528 -368 -1.5% $455.24 24,631 17 Nov 2025 Direct F1, F3
transaction ALNY Common Stock Sale $166,075 -364 -1.5% $456.25 24,267 17 Nov 2025 Direct F1, F4
transaction ALNY Common Stock Sale $119,836 -262 -1.1% $457.39 24,005 17 Nov 2025 Direct F1, F5
transaction ALNY Common Stock Sale $363,978 -794 -3.3% $458.41 23,211 17 Nov 2025 Direct F1, F6
transaction ALNY Common Stock Sale $286,052 -622 -2.7% $459.89 22,589 17 Nov 2025 Direct F1, F7
transaction ALNY Common Stock Sale $325,814 -707 -3.1% $460.84 21,882 17 Nov 2025 Direct F1, F8
transaction ALNY Common Stock Sale $149,213 -323 -1.5% $461.96 21,559 17 Nov 2025 Direct F1, F9
transaction ALNY Common Stock Sale $136,609 -295 -1.4% $463.08 21,264 17 Nov 2025 Direct F1, F10
holding ALNY Common Stock 537 17 Nov 2025 by Managed Account F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -8,161 -91% $0.000000 839 17 Nov 2025 Common Stock 8,161 $119.13 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the Reporting Person on August 14, 2025.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $451.41 to $451.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $454.92 to $455.45. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $455.97 to $456.94. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $457.00 to $457.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $458.01 to $458.94. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $459.40 to $460.36. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $460.46 to $461.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $461.50 to $462.39. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $462.82 to $463.46. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F12 This stock option was fully vested and exercisable as of December 1, 2021.